FDA approves Tryptyr eye drops for dry eye disease
The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr (acoltremon ophthalmic solution) for the treatment of signs and symptoms of dry eye disease. Approval of Tryptyr was granted to Alcon.
Post Views: 10
